Hemogenyx Pharmaceuticals (HEMO) Stock Chart & Stock Price History GBX 197.50 +6.25 (+3.27%) As of 03/28/2025 12:36 PM Eastern Add Compare Share Share Chart Stock AnalysisChartCompetitorsHeadlinesBuy This Stock Hemogenyx Pharmaceuticals Stock Price Performance 5 Day Performance+4.23%1 Month Performance-36.29%3 Month Performance-52.98%6 Month Performance+11,906.08%Year-To-Date Performance-50.87%1 Year Performance+11,121.59% Receive HEMO Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Hemogenyx Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address HEMO Stock Chart for Sunday, March, 30, 2025 HEMO Chart by TradingViewRemove Ads Hemogenyx Pharmaceuticals Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization03/28/2025GBX 193.80GBX 197.50+1.91%GBX 197.50GBX 182.5014,733 shs£7.04 million03/27/2025GBX 195.28GBX 193.80-0.76%GBX 198GBX 1864,801 shs£6.91 million03/26/2025GBX 189.49GBX 195.28+3.05%GBX 195.28GBX 185.5015,502 shs£6.96 million03/25/2025GBX 190GBX 189.49-0.27%GBX 195GBX 182.9831,793 shs£6.75 million03/24/2025GBX 181.50GBX 190+4.68%GBX 192GBX 180.5030,924 shs£6.77 million03/21/2025GBX 177.63GBX 181.50+2.18%GBX 190GBX 175.98152,277 shs£6.47 million03/20/2025GBX 169.16GBX 177.63+5.01%GBX 177.63GBX 168.5013,487 shs£6.33 million03/19/2025GBX 180.30GBX 169.16-6.18%GBX 189.50GBX 16065,729 shs£6.03 million03/18/2025GBX 182.19GBX 180.30-1.04%GBX 181GBX 17539,831 shs£6.43 million03/17/2025GBX 179.50GBX 182.19+1.50%GBX 189.50GBX 17838,056 shs£6.49 million Get the Latest News and Ratings for HEMO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Hemogenyx Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 03/14/2025GBX 185GBX 179.50-2.97%GBX 199.50GBX 17516,276 shs£6.40 million03/13/2025GBX 188.40GBX 185-1.80%GBX 199.50GBX 181.1967,237 shs£6.59 million03/12/2025GBX 193.55GBX 188.40-2.66%GBX 200GBX 184168,652 shs£6.72 million03/11/2025GBX 308.80GBX 193.55-37.32%GBX 219.50GBX 191.15389,107 shs£6.90 million03/10/2025GBX 308.80GBX 308.80GBX 320GBX 3017,451 shs£11.01 million03/07/2025GBX 320GBX 308.80-3.50%GBX 319.05GBX 302.803,403 shs£11.01 million03/06/2025GBX 308.98GBX 320+3.57%GBX 320GBX 3013,668 shs£11.41 million03/05/2025GBX 313.34GBX 308.98-1.39%GBX 319.05GBX 301.958,523 shs£11.01 million03/04/2025GBX 306.84GBX 313.34+2.12%GBX 319GBX 313.348,278 shs£11.17 million03/03/2025GBX 310GBX 306.84-1.02%GBX 319GBX 30537,535 shs£10.94 million02/28/2025GBX 302.81GBX 310+2.38%GBX 318.55GBX 31037,058 shs£11.05 million Related Companies Arecor Therapeutics Stock Price Chart OptiBiotix Health Stock Price Chart Sareum Stock Price Chart Poolbeg Pharma Stock Price Chart ImmuPharma Stock Price Chart Synairgen Stock Price Chart Oxford BioDynamics Stock Price Chart IXICO Stock Price Chart Fusion Antibodies Stock Price Chart Cizzle Biotechnology Stock Price Chart Receive HEMO Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Hemogenyx Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (LON:HEMO) was last updated on 3/30/2025 by MarketBeat.com Staff From Our PartnersTrump Treasure April 19Thanks to President Trump… A $900 investment across5 specific cryptos… Could gain 12,000% so quickly tha...Paradigm Press | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredThe Dirty Secret About Gold Mining Stocks...Here's something most gold analysts won't tell you: 90% of gold mining companies actually destroy sharehold...Golden Portfolio | SponsoredNvidia’s CEO: “This Will Be a Multitrillion-Dollar Industry."If you missed out on the big boom in Nvidia… Listen up, because according to Nvidia's own CEO… Elon Musk...Brownstone Research | SponsoredTrump doesn’t give a damnPorter Stansberry: “I met with Trump’s biggest backers… they’re scooping up these 10 stocks” I recently met...Porter & Company | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredWall Street’s “AI Oracle” Reveals Next Big Tech PlayA tiny American tech company could be at the center of the next big AI breakthrough. Wall Street's "AI Orac...InvestorPlace | SponsoredElon’s ‘Strike Squad’ sends these 9 stocks soaring?Elon Musk's DOGE 'strike squad' just revealed it's speeding up the rollout of a radical technology across the ...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Hemogenyx Pharmaceuticals Plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Hemogenyx Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.